Palex Medical SA has acquired Grupo Taper
Palex Medical SA, a leading distributor of medical equipment in Spain and Portugal, has acquired the healthcare business of Grupo Taper, with the objective to strengthen its position as a distributor company within the hospitality sector. Financial details have not been disclosed.
Founded in 1955, Palex Medical has three divisions: the hospital division that serves the needs of hospitals, clinics, medical centers and private practices; the lab and research division specializes in complete, integrated solutions for all types of anatomical pathology labs, research and diagnostic laboratories; and the specialty clinics division providing image diagnosis services.
Founded in 1989, Grupo Taper is a Spanish company that distributes equipment and products for medical centers, pathological anatomy labs, investigation and diagnosis for the food industry.
Oaklins' team in Spain advised the buyer in this transaction.
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more